Literature DB >> 12707244

Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury.

Costas J Schulze1, Wenjie Wang, Wilma L Suarez-Pinzon, Jolanta Sawicka, Grzegorz Sawicki, Richard Schulz.   

Abstract

BACKGROUND: We have previously reported that matrix metalloproteinase-2 (MMP-2) contributes to myocardial ischemia-reperfusion injury by degradation of troponin I, a regulatory element of the contractile proteins. MMP activities are also tightly regulated by tissue inhibitors of metalloproteinase (TIMPs). The change in TIMPs during acute myocardial ischemia-reperfusion injury is not clear. METHODS AND
RESULTS: Isolated rat hearts were perfused either aerobically for 75 minutes or subjected to 15, 20, or 25 minutes of global, no-flow ischemia followed by 30 minutes of aerobic reperfusion. During reperfusion after ischemia, there was a rapid, enhanced release of TIMP-4, the most abundant TIMP in the heart, into the coronary effluent, as shown both by reverse zymography and Western blot. There was a negative correlation between the recovery of cardiac mechanical function and the release of TIMP-4 during reperfusion in hearts subjected to different durations of ischemia. Immunogold electron microscopy revealed a close association of TIMP-4 with the sarcomeres in aerobically perfused hearts. Moreover, TIMP-4 was present only in thin myofilaments prepared from aerobically perfused hearts but not in ischemic-reperfused hearts. An enhanced MMP activity was shown in ischemic-reperfused hearts by in situ zymography.
CONCLUSIONS: Loss of TIMP-4 from the cardiac myocyte leads to an increase in net myocardial MMP activity that contributes to acute myocardial stunning injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707244     DOI: 10.1161/01.CIR.0000065603.09430.58

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.

Authors:  Jiqiu Chen; Ching-Hsuan Tung; Jennifer R Allport; Si Chen; Ralph Weissleder; Paul L Huang
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

2.  Protective action of doxycycline against diabetic cardiomyopathy in rats.

Authors:  N Yaras; M Sariahmetoglu; A Bilginoglu; A Aydemir-Koksoy; A Onay-Besikci; B Turan; R Schulz
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

Review 3.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.

Authors:  Linn Moore; Dong Fan; Ratnadeep Basu; Vijay Kandalam; Zamaneh Kassiri
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 4.  Myocardial matrix metalloproteinase-2: inside out and upside down.

Authors:  Ashley DeCoux; Merry L Lindsey; Francisco Villarreal; Ricardo A Garcia; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2014-09-28       Impact factor: 5.000

5.  Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.

Authors:  Mehrnoosh Saghizadeh; Andrei A Kramerov; Jian Tajbakhsh; Annette M Aoki; Charles Wang; Ning-Ning Chai; Julia Y Ljubimova; Takako Sasaki; Gabriel Sosne; Marc R J Carlson; Stanley F Nelson; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

6.  Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.

Authors:  M M Lalu; J Cena; R Chowdhury; A Lam; R Schulz
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

7.  Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.

Authors:  Veronika Wetzl; Svenja Lena Tiede; Lothar Faerber; Norbert Weissmann; Ralph Theo Schermuly; Hossein Ardeschir Ghofrani; Henning Gall
Journal:  Lung       Date:  2017-05-17       Impact factor: 2.584

8.  Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.

Authors:  Koichi Kaikita; Takanori Hayasaki; Toshiyuki Okuma; William A Kuziel; Hisao Ogawa; Motohiro Takeya
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.

Authors:  H León; I Baczkó; G Sawicki; P E Light; R Schulz
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

10.  TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure.

Authors:  Satoshi Yamamoto; Justin H Nguyen
Journal:  J Surg Res       Date:  2006-02-20       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.